Ascentage Pharma Group International (AAPG) Invested Capital (2023)

Ascentage Pharma Group International's Invested Capital history runs 4 years deep, the most recent figure standing at $85864.5 for Q4 2025.

• In Q4 2025, Invested Capital fell 97.96% year-over-year to $85864.5; the TTM figure through Dec 2025 stood at $250.5 million (changed N/A YoY), while the FY2025 annual figure was $84744.1, down 97.99% from the prior year.
• Invested Capital for Q4 2025 stood at $85864.5, down from $4.2 million in the prior quarter.
• The five-year high for Invested Capital was $246.2 million in Q4 2023, with the low at $53851.4 in Q4 2022.
• The 4-year median for Invested Capital is $2.1 million (2024), against an average of $62.6 million.
• The sharpest annual moves came in 2023 and 2024: Invested Capital surged 457150.1% in 2023, then plunged 98.29% in 2024.
• Ascentage Pharma Group International's Invested Capital stood at $53851.4 in 2022, then soared by 457150.1% to $246.2 million in 2023, then slumped by 98.29% to $4.2 million in 2024, then slumped by 97.96% to $85864.5 in 2025.
• Business Quant data shows AAPG's Invested Capital at $85864.5 in Q4 2025, $4.2 million in Q4 2024, and $246.2 million in Q4 2023.